• Tue news: 23andMe CEO no longer open to takeover. mRNA vaccines may boost cancer immunotherapy. BMS beats $6.4B lawsuit. CVS Health layoffs and potential breakup. JNJ abandoning proposed 340b plan. See more on our front page

Company wide reorg to align with the new areas (Onc, Vac, Chronic Care)?

anonymous

Guest
What's on the horizon for clinical and basic research with this new announcement? What happens to support staff for infectious diseases? Any word on in licensing within CC area?
 

<



Similar threads